News

Two exciting job opportunities at our Hørsholm offices

AFYX Therapeutics is a growing and we have two exciting job opportunities inside Finance & Accounting and Office & Warehouse Administration, respectively. See job posts directly on LInkedIn: Financial Accountant, Copenhagen Area (Hørsholm) Office &...

Cevidra SAS and AFYX Therapeutics A/S announce distribution and collaboration agreement

Hørsholm, Denmark – January 13, 2025 AFYX Therapeutics A/S and Cevidra SAS are pleased to announce a strategic partnership aimed at bringing innovative treatments for Head and Neck Cancer to the French market. Under this collaboration, Cevidra will serve as the local...

Er-Kim and AFYX Therapeutics A/S announce distribution and sales collaboration

Hørsholm, Denmark – January 6, 2025 Er-Kim and AFYX Therapeutics A/S announced today a distribution and sales collaboration for two AFYX products. The two companies have entered a mutual sales and distribution collaboration where Er-Kim will sell and distribute the...
AFYX report from our Annual General Meeting

AFYX report from our Annual General Meeting

Hørsholm, Denmark, April 03, 2024 As of August 2023, Dr. Claus Møller-San Pedro took over as the new CEO of Inphena ApS, now a part of AFYX Therapeutics A/S. During an Extraordinary General Meeting in December 2023 our Board of Directors (BOD) was expanded to 3...

Inphena has acquired all shares in AFYX Therapeutics

Inphena has acquired all shares in AFYX Therapeutics

Hørsholm, Denmark, January 09, 2024 Today, we are happy to announce that Inphena A/S has acquired all shares in AFYX Therapeutics A/S. The transaction came in place after the majority shareholders Sofinnova, Novo Holdings and the Lundbeck Foundation decided that the...

OUR LATEST INVESTOR PRESENTATION

Download here:

AFYX Presentation 2024 Investor Non-Confidential

AFYX THERAPEUTICS HQ

Slotsmarken 11, 1.tv.
DK-2970 Hørsholm
Denmark
VAT: 38793594
Phone: +45 7174 7174
info@afyxtx.com

INPHENA NORWAY

Gaustadalléen 21
NO-0349 Oslo
Norway
VAT: 922 558 221
Phone: +47 2396 7174

SIGN UP TO NEWSLETTER